A nurse is caring for a client who has a prescription for ceftriaxone. The nurse should monitor the client for which of the following adverse effects?
Constipation
Maculopapular rash
Pitting edema
Concentrated urine
The Correct Answer is B
B. Maculopapular rash is a potential adverse effect of ceftriaxone. It is a type of skin rash characterized by flat, red areas (macules) and raised, bumpy areas (papules). If a client develops a rash while taking ceftriaxone, it should be reported to the healthcare provider for evaluation.
A. Constipation is not a common adverse effect of ceftriaxone. It is more commonly associated with other medications or medical conditions unrelated to ceftriaxone.
C. Pitting edema is not a common adverse effect of ceftriaxone. It may occur as a result of other medical conditions or medications, but it is not specifically associated with ceftriaxone.
D. Concentrated urine is not a common adverse effect of ceftriaxone.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
A. Slurred speech can be a symptom of lithium toxicity. As lithium levels rise in the blood, it can affect neurological function, leading to symptoms such as confusion, drowsiness, tremors, and slurred speech.
B. Stooped posture is not typically associated with lithium toxicity. It is more commonly associated with musculoskeletal issues or neurological disorders rather than lithium toxicity.
C. Elevated blood pressure is not a typical symptom of lithium toxicity. Lithium can actually have a protective effect on blood pressure, and hypertension is not commonly associated with lithium toxicity.
D. Dry cough is not a symptom of lithium toxicity. It is more commonly associated with respiratory conditions or medication side effects rather than lithium toxicity.
Correct Answer is D
Explanation
D. One of the primary requirements of the iPledge program for sexually active females of childbearing potential is the use of two forms of contraception simultaneously, beginning one month before starting isotretinoin therapy, throughout therapy, and for one month after discontinuation of therapy. This is to ensure effective contraception and prevent pregnancy due to the teratogenic effects of isotretinoin.
A. While mammograms are important screening tests for breast cancer, they are not a requirement of the iPledge program for female clients receiving isotretinoin.
B. Papanicolaou (Pap) tests, which screen for cervical cancer, are not a requirement of the iPledge program. However, sexually active females of childbearing potential must have monthly pregnancy tests and must agree to use two forms of contraception simultaneously during isotretinoin therapy.
C. There is no requirement for clients to take a daily supplement of vitamin A prior to initiating isotretinoin therapy as part of the iPledge program.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today